DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $92,000 | +5.7% | 4,619 | +97.4% | 0.01% | +25.0% |
Q2 2021 | $87,000 | +17.6% | 2,340 | -19.2% | 0.00% | 0.0% |
Q1 2021 | $74,000 | -40.8% | 2,897 | -58.8% | 0.00% | -50.0% |
Q3 2020 | $125,000 | +278.8% | 7,024 | +288.5% | 0.01% | +166.7% |
Q1 2020 | $33,000 | -74.8% | 1,808 | -69.8% | 0.00% | -62.5% |
Q4 2019 | $131,000 | +1210.0% | 5,990 | +877.2% | 0.01% | +700.0% |
Q2 2019 | $10,000 | +11.1% | 613 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $9,000 | -25.0% | 613 | -47.4% | 0.00% | 0.0% |
Q4 2018 | $12,000 | -29.4% | 1,165 | +8.4% | 0.00% | 0.0% |
Q3 2018 | $17,000 | – | 1,075 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |